Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$90.19 - $110.4 $172,353 - $210,974
1,911 New
1,911 $210,000
Q3 2023

Oct 26, 2023

BUY
$95.53 - $114.62 $17,290 - $20,746
181 Added 9.23%
2,142 $207,000
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $1,814 - $2,021
-18 Reduced 0.91%
1,961 $213,000
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $188,123 - $220,698
1,979 New
1,979 $217,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $2,960 - $3,577
-29 Reduced 1.46%
1,961 $213,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $3,306 - $4,032
29 Added 1.48%
1,990 $236,000
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $1,399 - $1,548
-12 Reduced 0.61%
1,961 $232,000
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $180,805 - $219,575
1,973 New
1,973 $215,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Punch & Associates Investment Management, Inc. Portfolio

Follow Punch & Associates Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.